A prospective database of patients undergoing elective orthopedic surgery with hardware implantation was analyzed from Oct. 1, 2012, to Dec. 31, 2013. From May 2013 onwards, an intervention was implemented — during their preoperative visit, all of the patients watched an educational video about MRSA decontamination and were given chlorhexidine washcloths and oral rinse and nasal povidone-iodine solution to be used the night before and the morning of scheduled surgery. Thirty-day SSI rates were collected.
The SSI rate in the intervention group was 1.1 percent as compared to the control group, which had an SSI rate of 3.8 percent.
More articles on ASC quality:
Oregon Patient Safety Commission recognizes 2 ASCs
9 articles on ‘superbug’ outbreaks and scope cleaning
WHO: Ebola vaccination trials to begin in Guinea
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
